Company profile
Quest PharmaTech Inc.
OTC: QPTFF · Healthcare · Biotechnology
Canadian filerHQ Edmonton, ABReports USD
#1161 of 1,418 Healthcare companies by revenue
EA Score
——FH 75DQ —GM —SS 29
v0.1 · 35/100 weight · pillars only
↑ balance-sheet leverage, return on assets · ↓ workforce scale, Piotroski F
Methodology →Revenue TTM
$0
Rev growth YoY (TTM)
needs 8 qtrs
Net income (FY)
$3.6M
Employees
3
as of 2026-08-23
Market cap
$3.4M
as of 2026-08-23
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$00 CAD2025
Net income$3.6M5.0M CAD2025
Operating income-$511.5k-712.4k CAD2025
Total assets$20.5M27.8M CAD2025
Liabilities$981.3k1.3M CAD2025
Equity$19.5M26.5M CAD2025
Revenue trend
FY2018 – FY2025 · USD
FY18
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Quest PharmaTech Inc.’s revenue?
Quest PharmaTech Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a Infinity% net margin.
Peers · Healthcare
Mustang Bio, Inc.41DStimcell Energetics, Inc.20DPharmaTher Holdings Ltd.——nDatalyze Corp.47DElixxer Ltd.14DMoleculin Biotech, Inc.42DKey facts
CEORagupathy Madiyalakan
SectorHealthcare
IndustryBiotechnology
HeadquartersEdmonton, AB
ExchangeOTC: QPTFF
Employees3
IPO date2018-08-24
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.